Edwards Lifesciences (NYSE:EW) Price Target Raised to $75.00
Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Canaccord Genuity Group from $71.00 to $75.00 in a report released on Friday,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the medical research company’s stock. Several other equities research analysts also recently weighed in on EW. Evercore ISI cut their […]
Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Canaccord Genuity Group from $71.00 to $75.00 in a report released on Friday,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the medical research company’s stock. Several other equities research analysts also recently weighed in on EW. Evercore ISI cut their […]
